A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to ALL
Related studies linked through entity extraction aliases.
Umbilical Cord Blood Transplant for Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)
- Status
- UNKNOWN
- Phase
- PHASE2
Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders
- Status
- COMPLETED
- Phase
- N/A
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Testing the Re-Engineered Hospital Discharge
- Status
- COMPLETED
- Phase
- NA
Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies
- Status
- COMPLETED
- Phase
- EARLY_PHASE1